5th International Symposium on Ocular Pharmacology and Therapeutics (ISOPT), Monte Carlo, Monaco, March 11-14, 2004

Companies' Sessions
Senju (The Current Therapeutic Strategy for Ocular Diseases)

The Current Therapeutic Strategy for Ocular Diseases Chairpersons: H. Yamashita, A. Okumura		Back to Section List page

	Safety and efficacy of topical bepotastine besilate (TAU-284) in conjunctival allergen challenge model. T. Sekiya

	Safety and efficacy of topical difluprednate (SJE-2079) in patients with severe anterior uveitis. T. Ogawa

	Ocular hypotensive effect of a new "once-daily? eye-drops formulation of 0.5% timolol (Timolast(superscript: TM)) in comparison to Timoptol (superscript: TM) 0.5% administered twice-daily. : A 4-month multicentr crossover clinical trial. J. F. Rouland